TheraRadar
← Back
Data updated: Mar 29, 2026

ELKINS SINN

Infectious DiseaseDermatologyCardiovascular
Generics

ELKINS SINN is a generic drug manufacturer focused on Infectious Disease, Dermatology, Cardiovascular.

1946
Since
31
Drugs
-
Trials
149
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

DIPHENHYDRAMINE HYDROCHLORIDE 2025-11-14
LEUCOVORIN CALCIUM 2025-11-12
LIDOCAINE HYDROCHLORIDE 2025-10-02
Manufacturing (CMC)
PREDNISONE 2025-10-01
LIDOCAINE HYDROCHLORIDE 2025-09-26
Labeling
ERYTHROMYCIN 2025-09-23
LIDOCAINE HYDROCHLORIDE 2025-08-27
Manufacturing (CMC)
LIDOCAINE HYDROCHLORIDE 2025-08-22
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Infectious Disease 25%
1 drugs
Dermatology 25%
1 drugs
Cardiovascular 25%
1 drugs
Gastroenterology 25%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Pfizer big-pharma
Infectious Disease, Dermatology, Gastroenterology
APOTHECON specialty
Infectious Disease, Dermatology, Cardiovascular, Gastroenterology
Baxter specialty
Infectious Disease, Cardiovascular, Dermatology
B BRAUN specialty
Infectious Disease, Dermatology, Cardiovascular
BAUSCH specialty
Dermatology, Cardiovascular, Gastroenterology